Legend Biotech Files 6-K, Confirms 20-F Reporting

Ticker: LEGN · Form: 6-K · Filed: Sep 27, 2024 · CIK: 1801198

Legend Biotech Corp 6-K Filing Summary
FieldDetail
CompanyLegend Biotech Corp (LEGN)
Form Type6-K
Filed DateSep 27, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, administrative, reporting-status

TL;DR

Legend Biotech filed a 6-K, confirming it's a foreign private issuer and files 20-F. No new financials.

AI Summary

Legend Biotech Corporation filed a Form 6-K on September 27, 2024, to report its status as a foreign private issuer. The company, incorporated in E9 with its principal executive office in Somerset, New Jersey, confirmed it files annual reports under Form 20-F. This filing does not contain specific financial figures or operational updates.

Why It Matters

This filing is a routine administrative update for Legend Biotech, confirming its reporting status with the SEC and indicating it will continue to file annual reports on Form 20-F.

Risk Assessment

Risk Level: low — This is a routine administrative filing that does not contain new material financial or operational information.

Key Players & Entities

  • Legend Biotech Corporation (company) — Filer of the Form 6-K
  • 001-39307 (other) — SEC File Number
  • 2101 Cottontail Lane Somerset, New Jersey 08873 (location) — Principal executive office address
  • Form 20-F (document) — Annual report filing requirement
  • Form 6-K (document) — Type of filing

FAQ

What is the purpose of this Form 6-K filing?

The purpose of this Form 6-K is to report Legend Biotech Corporation's status as a foreign private issuer and to confirm that it files annual reports under cover of Form 20-F.

When was this Form 6-K filed?

This Form 6-K was filed on September 27, 2024.

What is Legend Biotech Corporation's SEC File Number?

Legend Biotech Corporation's SEC File Number is 001-39307.

Where are Legend Biotech Corporation's principal executive offices located?

Legend Biotech Corporation's principal executive offices are located at 2101 Cottontail Lane, Somerset, New Jersey 08873.

Does Legend Biotech Corporation file its annual reports on Form 40-F?

No, Legend Biotech Corporation indicated by check mark that it files annual reports under cover of Form 20-F, not Form 40-F.

Filing Stats: 370 words · 1 min read · ~1 pages · Grade level 15.1 · Accepted 2024-09-27 16:35:05

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Legend Biotech Corporation (Registrant) Date: September 27, 2024 /s/ Ying Huang Ying Huang, Ph.D. Chief Executive Officer

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.